Abstract
The use of standardized management protocols (SMPs) may improve patient outcomes for some critical care diseases. Whether SMPs improve outcomes after subarachnoid hemorrhage (SAH) is currently unknown. We aimed to study the effect of SMPs on 6-month mortality and neurologic outcomes following SAH. A systematic review of randomized control trials (RCTs) and observational studies was performed by searching multiple indexing databases from their inception through January 2019. Studies were limited to adult patients (age ≥ 18) with non-traumatic SAH reporting mortality, neurologic outcomes, delayed cerebral ischemia (DCI) and other important complications. Data on patient and SMP characteristics, outcomes and methodologic quality were extracted into a pre-piloted collection form. Methodologic quality of observational studies was assessed using the Newcastle–Ottawa scale, and RCT quality was reported as per the Cochrane risk of bias tool. A total of 11,260 studies were identified, of which 37 (34 full-length articles and 3 abstracts) met the criteria for inclusion. Two studies were RCTs and 35 were observational. SMPs were divided into four broad domains: management of acute SAH, early brain injury, DCI and general neurocritical care. The most common SMP design was control of DCI, with 22 studies assessing this domain of care. Overall, studies were of low quality; most described single-center case series with small patient sizes. Definitions of key terms and outcome reporting practices varied significantly between studies. DCI and neurologic outcomes in particular were defined inconsistently, leading to significant challenges in their interpretation. Given the substantial heterogeneity in reporting practices between studies, a meta-analysis for 6-month mortality and neurologic outcomes could not be performed, and the effect of SMPs on these measures thus remains inconclusive. Our systematic review highlights the need for large, rigorous RCTs to determine whether providing standardized, best-practice management through the use of a protocol impacts outcomes in critically ill patients with SAH.
Trial registration Registration number: CRD42017069173.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12028-019-00867-5/MediaObjects/12028_2019_867_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12028-019-00867-5/MediaObjects/12028_2019_867_Fig2_HTML.png)
Similar content being viewed by others
References
Nieuwkamp DJ, et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8(7):635–42.
Al-Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41(8):e519–36.
Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389(10069):655–66.
Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998;50(5):1413–8.
Dorhout Mees SM, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007. https://doi.org/10.1002/14651858.CD000277.pub3.
Ohman J, Heiskanen O. Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study. J Neurosurg. 1989;70(1):55–60.
Cowan JA Jr, et al. Outcomes after cerebral aneurysm clip occlusion in the United States: the need for evidence-based hospital referral. J Neurosurg. 2003;99(6):947–52.
Johnston SC. Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes. Stroke. 2000;31(1):111–7.
Naval NS, et al. Controversies in the management of aneurysmal subarachnoid hemorrhage. Crit Care Med. 2006;34(2):511–24.
Stevens RD, et al. Intensive care of aneurysmal subarachnoid hemorrhage: an international survey. Intensive Care Med. 2009;35(9):1556–66.
Diringer MN, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40.
Connolly ES Jr, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43(6):1711–37.
Alberts MJ, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke. 2005;36(7):1597–616.
Chang SY, Sevransky J, Martin GS. Protocols in the management of critical illness. Crit Care. 2012;16(2):306.
Brook AD, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999;27(12):2609–15.
Blackwood B, et al. Protocolized versus non-protocolized weaning for reducing the duration of mechanical ventilation in critically ill adult patients. Cochrane Database Syst Rev. 2010. https://doi.org/10.1002/14651858.CD006904.pub2.
Brower RG, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301–8.
English SW, et al. Protocol management of severe traumatic brain injury in intensive care units: a systematic review. Neurocrit Care. 2013;18(1):131–42.
McCredie VA, et al. Impact of ICU structure and processes of care on outcomes after severe traumatic brain injury: a multicenter cohort study. Crit Care Med. 2018;46(7):1139–49.
Pronovost PJ, Berenholtz SM, Needham DM. Translating evidence into practice: a model for large scale knowledge translation. BMJ. 2008;337:a1714.
Taran S, et al. The use of standardized management protocols for critically ill patients with non-traumatic subarachnoid hemorrhage: a protocol of a systematic review and meta-analysis. Syst Rev. 2018;7:53.
Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.
de Oliveira Manoel AL, et al. The critical care management of poor-grade subarachnoid haemorrhage. Crit Care. 2016;20:21.
Francoeur CL, Mayer SA. Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care. 2016;20(1):277.
Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44–58.
Camporota L, Brett S. Care bundles: implementing evidence or common sense? Crit Care. 2011;15(3):159.
Vergouwen MD, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391–5.
Wells G, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
Higgins JPT, Green S, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. http://handbook.cochrane.org.
Thomas JE, McGinnis G. Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting. Stroke. 2002;33(2):486–92.
Park J, et al. Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes. J Neurosurg. 2015;122(2):383–91.
Eide PK, et al. A randomized and blinded single-center trial comparing the effect of intracranial pressure and intracranial pressure wave amplitude-guided intensive care management on early clinical state and 12-month outcome in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2011;69(5):1105–15.
Hanggi D, et al. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Zentralbl Neurochir. 2009;70(2):61–7.
Hanggi D, et al. The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: results of a single center prospective Phase II trial. J Neurosurg. 2008;108(6):1192–9.
Kim DH, Haney CL, Van Ginhoven G. Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol. Neurocrit Care. 2005;3(1):11–5.
Latorre JG, et al. Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke. 2009;40(5):1644–52.
Lerch C, et al. Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(2):85–92.
Manoel AL, et al. St. Michael’s hospital protocol for the management of patients suffering from subarachnoid haemorrhage-a quality improvement initiative. Neurocrit Care. 2013;1:S259.
Mejia-Matilla JH, et al. Albumin in aneurysmal SAH: Effects of implementation of a protocol of continuous infusion on clinical outcomes. Neurocrit Care. 2015;1:S222.
Murphy A, et al. Changes in cerebral perfusion with induced hypertension in aneurysmal subarachnoid hemorrhage: a pilot and feasibility study. Neurocrit Care. 2017;27:1–8.
Thiele RH, et al. Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology. 2009;110(3):603–10.
Whitfield PC, et al. An audit of aneurysmal subarachnoid haemorrhage: earlier resuscitation and surgery reduces inpatient stay and deaths from rebleeding. J Neurol Neurosurg Psychiatry. 1996;60(3):301–6.
Boonyawanakij T, Tirakotai W, Liengudom A. Lumbar drainage and low rate of permanent shunt insertion after treating aneurysmal subarachnoid hemorrhage. J Med Assoc Thai. 2016;99:S47–53.
Naidech AM, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med. 2007;35(10):2383–9.
Naidech AM, et al. Medical complications drive length of stay after brain hemorrhage: a cohort study. Neurocrit Care. 2009;10(1):11–9.
Suarez JI, et al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683–90.
Armonda RA, Thomas JE, Rosenwasser RH. Early and aggressive treatment of medically intractable cerebral vasospasm with pentobarbital coma, cerebral angioplasty and ICP reduction. Neurosurg Focus. 1998;5(4):e7.
Awad IA, et al. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke. 1987;18(2):365–72.
Bailes JE, et al. Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg. 1990;72(4):559–66.
Barbarawi M, et al. Therapeutic approaches to cerebral vasospasm complicating ruptured aneurysm. Neurol Int. 2009;1(1):e13.
Boet R, Mee E. Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. Neurosurgery. 2000;47(3):602–6 discussion 606–7.
Corsten L, et al. Contemporary management of subarachnoid hemorrhage and vasospasm: the UIC experience. Surg Neurol. 2001;56(3):140–8 discussion 148–50.
Fandino J, et al. Clinical, angiographic, and sonographic findings after structured treatment of cerebral vasospasm and their relation to final outcomes. Acta Neurochir (Wien). 1999;141(7):677–90.
Kassell NF, et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery. 1982;11(3):337–43.
Kodama N, et al. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage Outcome in 217 patients. Surg Neurol. 2000;53(2):110–7 discussion 117–8.
Lannes M, et al. Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol. Neurocrit Care. 2012;16(3):354–62.
Ljunggren B, et al. Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine. J Neurosurg. 1984;61(5):864–73.
Martinez M, et al. Prognostic factors for neurological outcome in patients with non traumatic subarachnoid hemorrhage. Intensive Care Med. 2011;37:S252.
Morgan MK, et al. Aggressive management of aneurysmal subarachnoid haemorrhage based on a papaverine angioplasty protocol. J Clin Neurosci. 2000;7(4):305–8.
Mutoh T, et al. Goal-directed fluid management by bedside transpulmonary hemodynamic monitoring after subarachnoid hemorrhage. Stroke. 2007;38(12):3218–24.
Origitano TC, et al. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“triple-H” therapy) after subarachnoid hemorrhage. Neurosurgery. 1990;27(5):729–39 discussion 739–40.
Seiler RW, et al. Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: a prospective study including early operation, intravenous nimodipine, and transcranial Doppler ultrasound. Neurosurgery. 1988;23(5):598–604.
Seule MA, et al. Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm. Neurosurgery. 2009;64(1):86–92 discussion 92–3.
Solomon RA, Fink ME, Lennihan L. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery. 1988;23(6):699–704.
Yonekawa Y, et al. Aneurysm surgery in the acute stage: results of structured treatment. Neurol Med Chir (Tokyo). 1998;38(Suppl):45–9.
Vergouw LJM, et al. High early fluid input after aneurysmal subarachnoid hemorrhage: combined report of association with delayed cerebral ischemia and feasibility of cardiac output-guided fluid restriction. J Intensive Care Med. 2017. https://doi.org/10.1177/0885066617732747.
Frontera JA, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke. 2009;40(6):1963–8.
de Oliveira Manoel AL, et al. Common data elements for unruptured intracranial aneurysms and aneurysmal subarachnoid hemorrhage: recommendations from the working group on hospital course and acute therapies—proposal of a multidisciplinary research group. Neurocrit Care. 2019;30 Suppl 1:36. https://doi.org/10.1007/s12028-019-00726-3.
Damani R, et al. Common Data Element for Unruptured Intracranial Aneurysm and Subarachnoid Hemorrhage: recommendations from Assessments and Clinical Examination Workgroup/Subcommittee. Neurocrit Care. 2019;30(Suppl 1):28–35.
Suarez JI, et al. Common data elements for unruptured intracranial aneurysms and subarachnoid hemorrhage clinical research: a National Institute for Neurological Disorders and Stroke and National Library of Medicine Project. Neurocrit Care. 2019;30(Suppl 1):4–19.
Bijlenga P, et al. Common data elements for subarachnoid hemorrhage and unruptured intracranial aneurysms: recommendations from the working group on subject characteristics. Neurocrit Care. 2019;30(Suppl 1):20–7.
Stienen MN, et al. Prioritization and timing of outcomes and endpoints after aneurysmal subarachnoid hemorrhage in clinical trials and observational studies: proposal of a Multidisciplinary Research Group. Neurocrit Care. 2019;30(Suppl 1):102–13.
Maas AI, et al. Re-orientation of clinical research in traumatic brain injury: report of an international workshop on comparative effectiveness research. J Neurotrauma. 2012;29(1):32–46.
Acknowledgements
Thank you for considering this manuscript for publication in the Journal of Neurocritical Care. On behalf of my co-authors, I, Dr. Shaurya Taran, confirm that the following manuscript complies with all instructions to authors as outlined in the submission information package. I additionally confirm that the authorship requirements have been met and that all co-authors have reviewed and approved the final manuscript for submission.
Funding
Finally, this work was not supported by any external grants or funding.
Author information
Authors and Affiliations
Contributions
ST participated in study planning, data screening, acquisition, and analysis, appraising the quality of studies, manuscript preparation and proofreading, and critical revisions. VT participated in data screening, acquisition, and analysis, and manuscript proofreading. JMS participated in study planning and manuscript proofreading. SWE participated in study planning and manuscript proofreading. VAM participated in study planning, develo** the search strategy, manuscript preparation and proofreading, and critical revisions.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Taran, S., Trivedi, V., Singh, J.M. et al. The Use of Standardized Management Protocols for Critically Ill Patients with Non-traumatic Subarachnoid Hemorrhage: A Systematic Review. Neurocrit Care 32, 858–874 (2020). https://doi.org/10.1007/s12028-019-00867-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-019-00867-5